drug development

Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...

NANJING, China and BASILDON, UK — September 18, 2026 IMPACT Therapeutics and Pharmanovia announced that the Committee for Medicinal...

Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...

Germantown, Maryland, U.S., September 21, 2026 Precigen has announced that the U.S. Food and Drug Administration (FDA) has granted...

Bridgewater, New Jersey, U.S., September 21, 2026 Insmed has announced that the U.S. Food and Drug Administration (FDA) has...

Marina del Rey, California, U.S., September 21, 2026 Armata Pharmaceuticals announced that new data evaluating AP-SA02, its investigational bacteriophage...

Parsippany, New Jersey, September 21, 2026 Teva Pharmaceuticals has announced new real-world data for UZEDY® (risperidone) extended-release injectable suspension,...

Shanghai and Hong Kong, PRC, September 21, 2026 Antengene Corporation Limited has announced the dosing of the first patient...

Tel Aviv, Israel, September18, 2026 Teva Pharmaceutical Industries Ltd. has announced new post hoc clinical data for TEV-‘749, its...

Washington, D.C., September 20, 2026 The Heart Failure Society of America (HFSA) has announced the late-breaking clinical research program...